Dow Up 0.45% Nasdaq Up 0.40%

Conatus Pharmaceuticals Inc. (CNAT)

-NasdaqGM
2.34 Down 0.21(8.24%) 4:00PM EDT
|After Hours : 2.35 Up 0.01 (0.43%) 7:25PM EDT
Prev Close:2.55
Open:2.50
Bid:2.20 x 1500
Ask:3.09 x 2000
1y Target Est:12.00
Beta:-0.589206
Earnings Date:Aug 3 - Aug 8 (Est.)
Day's Range:2.33 - 2.57
52wk Range:1.40 - 7.12
Volume:231,720
Avg Vol (3m):217,565
Market Cap:49.72M
P/E (ttm):N/A
EPS (ttm):-1.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CNAT

Comparison

Symbol% ChgMkt Cap
CNATDown 8.24%49.72M
ICPTDown 2.66%3.25B
GALTDown 2.34%36.03M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.48
Quarterly EPS Est (Jun-16) :-0.35
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-1.72

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback